文献速递癫痫

药物难治性癫痫的发病率与患病率:系统综述与荟萃分析

Incidence and Prevalence of Drug-Resistant Epilepsy: A Systematic Review and Meta-analysis.
PubMed 文献 · Neurology · 2021-03-15

该系统综述与荟萃分析纳入103篇观察性研究,评估药物难治性癫痫(DRE)的发病率与患病率及其预测因素。儿童研究累积发病率为25.0%(95%CI 16.8-34.3),成人/混合年龄为14.6%(95%CI 8.8-21.6);人群/社区患病率为13.7%(95%CI 9.2-19.0),门诊队列为36.3%(95%CI 30.4-42.4)。Meta回归证实门诊人群和局灶性癫痫的DRE患病率更高,并识别出多种预测因素。

要点

  • 儿童DRE累积发病率25.0%,高于成人/混合年龄的14.6%。
  • 门诊队列DRE患病率36.3%,显著高于人群/社区的13.7%。
  • 常见预测因素包括神经功能缺损、EEG异常和症状性癫痫。

核心结论

  • DRE的发病率与患病率因人群不同而异,门诊人群和局灶性癫痫的患病率更高。
  • 识别出多种DRE预测因素与相关因素,有助于规划癫痫服务包括癫痫手术。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase和Web of Science,最终纳入103篇符合标准的观察性研究。
  • 采用双反正弦变换和随机效应模型进行荟萃分析,并利用研究层面数据做随机效应Meta回归。

主要发现

  • 儿童研究DRE累积发病率为25.0%(95%CI 16.8-34.3),成人/混合年龄研究为14.6%(95%CI 8.8-21.6)。
  • 人群/社区基础人群DRE患病率为13.7%(95%CI 9.2-19.0),门诊基础队列为36.3%(95%CI 30.4-42.4)。
  • Meta回归证实门诊人群和局灶性癫痫的DRE患病率更高。
  • 报告最多的预测因素包括神经功能缺损、EEG异常和症状性癫痫;报告最多的遗传预测因素是ABCB1基因多态性。

临床怎么用

  • 可依据不同人群的DRE发病率与患病率估计来规划癫痫服务,包括癫痫手术资源配置。
  • 对具有神经功能缺损、EEG异常或症状性癫痫等预测因素的患者,应警惕DRE风险。

局限性

  • 研究间异质性高,且存在偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the incidence and prevalence of drug-resistant epilepsy (DRE) as well as its predictors and correlates, we conducted a systematic review and meta-analysis of observational studies. METHODS: Our protocol was registered with PROSPERO, and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-analysis of Observational Studies in Epidemiology reporting standards were followed. We searched MEDLINE, Embase, and Web of Science. We used a double arcsine transformation and random-effects models to perform our meta-analyses. We performed random-effects meta-regressions using study-level data. RESULTS: Our search strategy identified 10,794 abstracts. Of these, 103 articles met our eligibility criteria. There was high interstudy heterogeneity and risk of bias. The cumulative incidence of DRE was 25.0% (95% confidence interval [CI]: 16.8-34.3) in child studies but 14.6% (95% CI: 8.8-21.6) in adult/mixed age studies. The prevalence of DRE was 13.7% (95% CI: 9.2-19.0) in population/community-based populations but 36.3% (95% CI: 30.4-42.4) in clinic-based cohorts. Meta-regression confirmed that the prevalence of DRE was higher in clinic-based populations and in focal epilepsy. Multiple predictors and correlates of DRE were identified. The most reported of these were having a neurologic deficit, an abnormal EEG, and symptomatic epilepsy. The most reported genetic predictors of DRE were polymorphisms of the ABCB1 gene. CONCLUSIONS: Our observations provide a basis for estimating the incidence and prevalence of DRE, which vary between populations. We identified numerous putative DRE predictors and correlates. These findings are important to plan epilepsy services, including epilepsy surgery, a crucial treatment option for people with disabling seizures and DRE.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Sultana B, Panzini MA, Veilleux Carpentier A, et al. Incidence and Prevalence of Drug-Resistant Epilepsy: A Systematic Review and Meta-analysis. Neurology. 2021. PMID: 33722992. doi:10.1212/WNL.0000000000011839

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。